1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing target patient population
5.1.1.2. Rising patient preference for minimally invasive procedures
5.1.1.3. Investment & funding by government and private organizations
5.1.1.4. Technology advancements in embolotherapy devices
5.1.1.5. Favorable reimbursement scenario for minimally invasive surgeries
5.1.2. Restraints
5.1.2.1. Lack of sufficient evidence & unfavorable regulatory scenario
5.1.2.2. Strong market positioning of alternative therapies
5.1.3. Opportunities
5.1.3.1. Growth opportunities in emerging markets
5.1.3.2. Expanding applications of embolization devices
5.1.4. Challenges
5.1.4.1. Lack of skilled surgeons
5.1.4.2. High cost and resulting difficulties in accessing embolization in developing countries
5.2. Cumulative Impact of COVID-19

6. Embolotherapy Market, by Product
6.1. Introduction
6.2. Embolic Agents
6.2.1. Detachable Balloons
6.2.2. Embolic Coils
6.2.3. Embolic Plug Systems
6.2.4. Liquid Embolic Agents
6.2.5. Microspheres
6.3. Support Devices
6.3.1. Guidewires
6.3.2. Microcatheters

7. Embolotherapy Market, by Disease Indication
7.1. Introduction
7.2. Cancer
7.3. Gastrointestinal Disorders
7.4. Neurological Diseases
7.5. Peripheral Vascular Disease
7.6. Urological & Nephrological Disorders

8. Embolotherapy Market, by Procedure
8.1. Introduction
8.2. Transarterial Chemoembolization
8.3. Transcatheter Arterial Embolization
8.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9. Embolotherapy Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Hospitals and Clinics

10. Americas Embolotherapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Embolotherapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Embolotherapy Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Acandis GmbH
14.3. Balt Extrusion
14.4. Boston Scientific Corporation
14.5. BTG plc
14.6. Cook Medical Incorporated
14.7. Johnson & Johnson
14.8. Kaneka Corporation
14.9. Medtronic plc
14.10. Meril Life Sciences Pvt., Ltd.
14.11. Merit Medical Systems Inc
14.12. Penumbra, Inc.
14.13. Sirtex Medical Limited
14.14. Stryker Corporation
14.15. Terumo Corporation

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL EMBOLOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL EMBOLOTHERAPY MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2027 (%)
FIGURE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2027
FIGURE 27. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2027 (%)
FIGURE 38. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2020 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2027
FIGURE 40. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, 2018-2027 (USD MILLION)
FIGURE 43. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, 2018-2027 (USD MILLION)
FIGURE 45. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 46. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 47. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2027
FIGURE 49. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
FIGURE 50. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2027 (USD MILLION)
FIGURE 52. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 53. AMERICAS EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. ARGENTINA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. BRAZIL EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. CANADA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MEXICO EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. CHINA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. INDIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. INDONESIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. JAPAN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. MALAYSIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. SINGAPORE EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. TAIWAN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. THAILAND EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. FRANCE EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. GERMANY EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. ITALY EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. QATAR EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. RUSSIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SPAIN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. GLOBAL EMBOLOTHERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL EMBOLOTHERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EMBOLOTHERAPY MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL EMBOLOTHERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DETACHABLE BALLOONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY EMBOLIC PLUG SYSTEMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY SUPPORT DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY DISEASE INDICATION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY UROLOGICAL & NEPHROLOGICAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL EMBOLIZATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL EMBOLOTHERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. AMERICAS EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. ARGENTINA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. BRAZIL EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. CANADA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. MEXICO EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. AUSTRALIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. CHINA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. INDIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. INDONESIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. JAPAN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. MALAYSIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. PHILIPPINES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. SINGAPORE EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. SOUTH KOREA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. TAIWAN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. THAILAND EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. FRANCE EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. GERMANY EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. ITALY EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 48. NETHERLANDS EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. QATAR EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. RUSSIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. SAUDI ARABIA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. SOUTH AFRICA EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. SPAIN EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. UNITED ARAB EMIRATES EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. UNITED KINGDOM EMBOLOTHERAPY MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL EMBOLOTHERAPY MARKET: SCORES
TABLE 57. GLOBAL EMBOLOTHERAPY MARKET: BUSINESS STRATEGY
TABLE 58. GLOBAL EMBOLOTHERAPY MARKET: PRODUCT SATISFACTION
TABLE 59. GLOBAL EMBOLOTHERAPY MARKET: RANKING
TABLE 60. GLOBAL EMBOLOTHERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 61. GLOBAL EMBOLOTHERAPY MARKET: MERGER & ACQUISITION
TABLE 62. GLOBAL EMBOLOTHERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 63. GLOBAL EMBOLOTHERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 64. GLOBAL EMBOLOTHERAPY MARKET: INVESTMENT & FUNDING
TABLE 65. GLOBAL EMBOLOTHERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 66. GLOBAL EMBOLOTHERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Acandis GmbH
Balt Extrusion
Boston Scientific Corporation
BTG plc
Cook Medical Incorporated
Johnson & Johnson
Kaneka Corporation
Medtronic plc
Meril Life Sciences Pvt., Ltd.
Merit Medical Systems Inc
Penumbra, Inc.
Sirtex Medical Limited
Stryker Corporation
Terumo Corporation